Comparable efficacy with etoricoxib 30mg and ibuprofen 2400mg in treating hip or knee OA .
A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis
Osteoarthritis Cartilage. 2007 Dec;15(12):1348-56. Epub 2007 Jul 16548 patients with osteoarthritis (OA) of the knee or hip were randomized to receive one of two treatments. The first group took etoricoxib (30 mg) once a day and the second group took ibuprofen (800 mg) three times a day (for a total of 2400 mg).The co-primary outcomes were pain, function and patient global assessment. Results indicated that there was comparable efficacy between the etoricoxib (30mg) and ibuprofen (2400mg) treatments. The two interventions were also significantly superior to the placebo.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
